Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Herzliya
- Most recent report
- 6-K, filed Sep 8, 2026
- Filings on record
- 119 filings
- On EDGAR
- CIK 1857030
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Emerging growth company
Financials 8 of 74
- 6-K Report a foreign issuer made public elsewhere Sep 8, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 26, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 24, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 11, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 4, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 22, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 22, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 15, 2026
Prospectuses and Registrations 3
Ownership 8 of 9
- 4 Insider reported a trade Aug 24, 2026
- 3 Insider reported their initial holding Apr 20, 2026
- 3 Insider reported their initial holding Apr 20, 2026
- 3 Insider reported their initial holding Apr 20, 2026
- 3 Insider reported their initial holding Apr 16, 2026
- 3 Insider reported their initial holding Apr 16, 2026
- 3 Insider reported their initial holding Apr 16, 2026
- SCHEDULE 13D Large holder reported an active stake Dec 9, 2025
Other 8 of 33
- 6-K/A Report a foreign issuer made public elsewhere, amended Aug 27, 2026
- D Aug 19, 2026
- 6-K/A Report a foreign issuer made public elsewhere, amended Jul 27, 2026
- UPLOAD Comment letter from SEC staff Aug 29, 2025
- CORRESP Reply to SEC staff Aug 7, 2025
- UPLOAD Comment letter from SEC staff Jul 15, 2025
- NT 20-F May 1, 2025
- 6-K/A Report a foreign issuer made public elsewhere, amended Jan 31, 2025
Everything here comes from Intercure Ltd.'s own filings on SEC EDGAR. The filing list is rechecked every hour.